Illumina Body Map 2, young vs old
Gene Symbol | Gene ID | Gene Info |
---|---|---|
TBX1
|
ENSG00000184058.8 | T-box transcription factor 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
TBX1 | hg19_v2_chr22_+_19744226_19744226 | -0.14 | 4.4e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chrX_+_123480194 | 4.47 |
ENST00000371139.4
|
SH2D1A
|
SH2 domain containing 1A |
chr6_-_31560729 | 4.41 |
ENST00000340027.5
ENST00000376073.4 ENST00000376072.3 |
NCR3
|
natural cytotoxicity triggering receptor 3 |
chr12_-_53594227 | 4.29 |
ENST00000550743.2
|
ITGB7
|
integrin, beta 7 |
chr3_+_48264816 | 4.12 |
ENST00000296435.2
ENST00000576243.1 |
CAMP
|
cathelicidin antimicrobial peptide |
chr14_+_22689792 | 4.07 |
ENST00000390462.1
|
TRAV35
|
T cell receptor alpha variable 35 |
chr11_-_64511789 | 3.84 |
ENST00000419843.1
ENST00000394430.1 |
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
chr19_+_544034 | 3.75 |
ENST00000592501.1
ENST00000264553.3 |
GZMM
|
granzyme M (lymphocyte met-ase 1) |
chr20_-_1538319 | 3.49 |
ENST00000381621.1
|
SIRPD
|
signal-regulatory protein delta |
chr19_-_51875894 | 3.42 |
ENST00000600427.1
ENST00000595217.1 ENST00000221978.5 |
NKG7
|
natural killer cell group 7 sequence |
chr2_+_7865923 | 3.39 |
ENST00000417930.1
|
AC092580.4
|
AC092580.4 |
chr17_-_7080227 | 3.34 |
ENST00000574330.1
|
ASGR1
|
asialoglycoprotein receptor 1 |
chr7_-_38389573 | 3.27 |
ENST00000390344.2
|
TRGV5
|
T cell receptor gamma variable 5 |
chr11_+_60223312 | 2.84 |
ENST00000532491.1
ENST00000532073.1 ENST00000534668.1 ENST00000528313.1 ENST00000533306.1 |
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1 |
chr5_+_54320078 | 2.82 |
ENST00000231009.2
|
GZMK
|
granzyme K (granzyme 3; tryptase II) |
chr17_-_42452063 | 2.80 |
ENST00000588098.1
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) |
chr12_+_120502441 | 2.76 |
ENST00000446727.2
|
CCDC64
|
coiled-coil domain containing 64 |
chr4_+_156824840 | 2.74 |
ENST00000536354.2
|
TDO2
|
tryptophan 2,3-dioxygenase |
chr12_-_45269430 | 2.73 |
ENST00000395487.2
|
NELL2
|
NEL-like 2 (chicken) |
chr1_-_156786634 | 2.63 |
ENST00000392306.2
ENST00000368199.3 |
SH2D2A
|
SH2 domain containing 2A |
chr2_+_98330009 | 2.59 |
ENST00000264972.5
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa |
chr16_+_12058961 | 2.59 |
ENST00000053243.1
|
TNFRSF17
|
tumor necrosis factor receptor superfamily, member 17 |
chr7_-_142240014 | 2.58 |
ENST00000390363.2
|
TRBV9
|
T cell receptor beta variable 9 |
chr2_+_204571198 | 2.58 |
ENST00000374481.3
ENST00000458610.2 ENST00000324106.8 |
CD28
|
CD28 molecule |
chr8_+_22019168 | 2.54 |
ENST00000318561.3
ENST00000521315.1 ENST00000437090.2 ENST00000520605.1 ENST00000522109.1 ENST00000524255.1 ENST00000523296.1 ENST00000518615.1 |
SFTPC
|
surfactant protein C |
chr4_-_71532668 | 2.49 |
ENST00000510437.1
|
IGJ
|
immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides |
chr12_+_10183271 | 2.49 |
ENST00000355819.1
|
CLEC9A
|
C-type lectin domain family 9, member A |
chr11_+_60223225 | 2.47 |
ENST00000524807.1
ENST00000345732.4 |
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1 |
chr1_-_156786530 | 2.47 |
ENST00000368198.3
|
SH2D2A
|
SH2 domain containing 2A |
chr11_+_71846764 | 2.44 |
ENST00000456237.1
ENST00000442948.2 ENST00000546166.1 |
FOLR3
|
folate receptor 3 (gamma) |
chr14_-_106733624 | 2.29 |
ENST00000390610.2
|
IGHV1-24
|
immunoglobulin heavy variable 1-24 |
chr7_-_142176790 | 2.29 |
ENST00000390369.2
|
TRBV7-4
|
T cell receptor beta variable 7-4 (gene/pseudogene) |
chr17_-_38721711 | 2.29 |
ENST00000578085.1
ENST00000246657.2 |
CCR7
|
chemokine (C-C motif) receptor 7 |
chr19_-_55458860 | 2.27 |
ENST00000592784.1
ENST00000448121.2 ENST00000340844.2 |
NLRP7
|
NLR family, pyrin domain containing 7 |
chr19_-_7764281 | 2.25 |
ENST00000360067.4
|
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23) |
chr17_-_72527605 | 2.25 |
ENST00000392621.1
ENST00000314401.3 |
CD300LB
|
CD300 molecule-like family member b |
chr14_+_22631122 | 2.20 |
ENST00000390458.3
|
TRAV29DV5
|
T cell receptor alpha variable 29/delta variable 5 (gene/pseudogene) |
chr1_+_209929494 | 2.20 |
ENST00000367026.3
|
TRAF3IP3
|
TRAF3 interacting protein 3 |
chr11_+_71846748 | 2.19 |
ENST00000445078.2
|
FOLR3
|
folate receptor 3 (gamma) |
chr14_-_106573756 | 2.17 |
ENST00000390601.2
|
IGHV3-11
|
immunoglobulin heavy variable 3-11 (gene/pseudogene) |
chr20_+_30640004 | 2.17 |
ENST00000520553.1
ENST00000518730.1 ENST00000375852.2 |
HCK
|
hemopoietic cell kinase |
chr4_-_71532601 | 2.17 |
ENST00000510614.1
|
IGJ
|
immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides |
chrX_+_123480375 | 2.15 |
ENST00000360027.4
|
SH2D1A
|
SH2 domain containing 1A |
chr7_+_142020496 | 2.14 |
ENST00000390381.3
|
TRBV5-1
|
T cell receptor beta variable 5-1 |
chr16_+_12059050 | 2.12 |
ENST00000396495.3
|
TNFRSF17
|
tumor necrosis factor receptor superfamily, member 17 |
chr1_-_157670647 | 2.12 |
ENST00000368184.3
|
FCRL3
|
Fc receptor-like 3 |
chr1_+_209929377 | 2.12 |
ENST00000400959.3
ENST00000367025.3 |
TRAF3IP3
|
TRAF3 interacting protein 3 |
chr7_-_142120321 | 2.11 |
ENST00000390377.1
|
TRBV7-7
|
T cell receptor beta variable 7-7 |
chr12_-_45269251 | 2.11 |
ENST00000553120.1
|
NELL2
|
NEL-like 2 (chicken) |
chr2_-_192016316 | 2.10 |
ENST00000358470.4
ENST00000432798.1 ENST00000450994.1 |
STAT4
|
signal transducer and activator of transcription 4 |
chr19_-_10213335 | 2.08 |
ENST00000592641.1
ENST00000253109.4 |
ANGPTL6
|
angiopoietin-like 6 |
chr15_-_38852251 | 2.08 |
ENST00000558432.1
|
RASGRP1
|
RAS guanyl releasing protein 1 (calcium and DAG-regulated) |
chr7_-_142169013 | 2.07 |
ENST00000454561.2
|
TRBV5-4
|
T cell receptor beta variable 5-4 |
chr17_-_34524157 | 2.05 |
ENST00000378354.4
ENST00000394484.1 |
CCL3L3
|
chemokine (C-C motif) ligand 3-like 3 |
chr7_+_142000747 | 2.05 |
ENST00000455382.2
|
TRBV2
|
T cell receptor beta variable 2 |
chr11_+_107643129 | 2.05 |
ENST00000447610.1
|
AP001024.2
|
Uncharacterized protein |
chr2_+_90229045 | 2.04 |
ENST00000390278.2
|
IGKV1D-42
|
immunoglobulin kappa variable 1D-42 (non-functional) |
chr12_-_45269769 | 2.02 |
ENST00000548826.1
|
NELL2
|
NEL-like 2 (chicken) |
chr21_-_46340807 | 2.02 |
ENST00000397846.3
ENST00000524251.1 ENST00000522688.1 |
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
chr1_+_207070775 | 2.00 |
ENST00000391929.3
ENST00000294984.2 ENST00000367093.3 |
IL24
|
interleukin 24 |
chr17_-_37934466 | 1.99 |
ENST00000583368.1
|
IKZF3
|
IKAROS family zinc finger 3 (Aiolos) |
chrX_+_123480421 | 1.99 |
ENST00000477673.2
|
SH2D1A
|
SH2 domain containing 1A |
chr6_-_25042390 | 1.96 |
ENST00000606385.1
|
RP11-367G6.3
|
RP11-367G6.3 |
chr7_+_74191613 | 1.94 |
ENST00000442021.2
|
NCF1
|
neutrophil cytosolic factor 1 |
chr1_-_25256368 | 1.93 |
ENST00000308873.6
|
RUNX3
|
runt-related transcription factor 3 |
chr20_-_42355629 | 1.92 |
ENST00000373003.1
|
GTSF1L
|
gametocyte specific factor 1-like |
chr1_+_209929446 | 1.92 |
ENST00000479796.1
|
TRAF3IP3
|
TRAF3 interacting protein 3 |
chr1_-_154127518 | 1.91 |
ENST00000368559.3
ENST00000271854.3 |
NUP210L
|
nucleoporin 210kDa-like |
chr1_+_172628154 | 1.91 |
ENST00000340030.3
ENST00000367721.2 |
FASLG
|
Fas ligand (TNF superfamily, member 6) |
chr12_-_54691668 | 1.91 |
ENST00000553198.1
|
NFE2
|
nuclear factor, erythroid 2 |
chr11_-_118213455 | 1.91 |
ENST00000300692.4
|
CD3D
|
CD3d molecule, delta (CD3-TCR complex) |
chr16_-_50715239 | 1.90 |
ENST00000330943.4
ENST00000300590.3 |
SNX20
|
sorting nexin 20 |
chr22_+_39966758 | 1.88 |
ENST00000407673.1
ENST00000401624.1 ENST00000404898.1 ENST00000402142.3 ENST00000336649.4 ENST00000400164.3 |
CACNA1I
|
calcium channel, voltage-dependent, T type, alpha 1I subunit |
chr1_-_36948879 | 1.87 |
ENST00000373106.1
ENST00000373104.1 ENST00000373103.1 |
CSF3R
|
colony stimulating factor 3 receptor (granulocyte) |
chr16_+_28943260 | 1.86 |
ENST00000538922.1
ENST00000324662.3 ENST00000567541.1 |
CD19
|
CD19 molecule |
chr1_-_179457805 | 1.86 |
ENST00000600581.1
|
AL160286.1
|
Uncharacterized protein |
chr7_-_38403077 | 1.85 |
ENST00000426402.2
|
TRGV2
|
T cell receptor gamma variable 2 |
chr5_+_110559312 | 1.85 |
ENST00000508074.1
|
CAMK4
|
calcium/calmodulin-dependent protein kinase IV |
chr2_-_219031709 | 1.85 |
ENST00000295683.2
|
CXCR1
|
chemokine (C-X-C motif) receptor 1 |
chr7_-_142099977 | 1.84 |
ENST00000390359.3
|
TRBV7-8
|
T cell receptor beta variable 7-8 |
chr17_-_47308128 | 1.83 |
ENST00000413580.1
ENST00000511066.1 |
PHOSPHO1
|
phosphatase, orphan 1 |
chr10_-_135150367 | 1.81 |
ENST00000368555.3
ENST00000252939.4 ENST00000368558.1 ENST00000368556.2 |
CALY
|
calcyon neuron-specific vesicular protein |
chr2_+_204571375 | 1.79 |
ENST00000374478.4
|
CD28
|
CD28 molecule |
chr1_-_169680745 | 1.78 |
ENST00000236147.4
|
SELL
|
selectin L |
chr1_-_36947120 | 1.77 |
ENST00000361632.4
|
CSF3R
|
colony stimulating factor 3 receptor (granulocyte) |
chr1_+_32716857 | 1.76 |
ENST00000482949.1
ENST00000495610.2 |
LCK
|
lymphocyte-specific protein tyrosine kinase |
chr1_+_32716840 | 1.76 |
ENST00000336890.5
|
LCK
|
lymphocyte-specific protein tyrosine kinase |
chr6_-_108145499 | 1.76 |
ENST00000369020.3
ENST00000369022.2 |
SCML4
|
sex comb on midleg-like 4 (Drosophila) |
chr19_+_19779589 | 1.76 |
ENST00000541458.1
|
ZNF101
|
zinc finger protein 101 |
chr4_-_90757364 | 1.74 |
ENST00000508895.1
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor) |
chr15_+_89922345 | 1.74 |
ENST00000558982.1
|
LINC00925
|
long intergenic non-protein coding RNA 925 |
chr15_-_80263506 | 1.74 |
ENST00000335661.6
|
BCL2A1
|
BCL2-related protein A1 |
chr14_+_22538811 | 1.73 |
ENST00000390450.3
|
TRAV22
|
T cell receptor alpha variable 22 |
chr3_-_172019686 | 1.73 |
ENST00000596321.1
|
AC092964.2
|
Uncharacterized protein |
chr7_+_5920429 | 1.73 |
ENST00000242104.5
|
OCM
|
oncomodulin |
chr7_-_142139783 | 1.72 |
ENST00000390374.3
|
TRBV7-6
|
T cell receptor beta variable 7-6 |
chr22_+_23010756 | 1.70 |
ENST00000390304.2
|
IGLV3-27
|
immunoglobulin lambda variable 3-27 |
chr19_+_7741968 | 1.70 |
ENST00000597445.1
|
C19orf59
|
chromosome 19 open reading frame 59 |
chr1_-_27953031 | 1.70 |
ENST00000374003.3
|
FGR
|
feline Gardner-Rasheed sarcoma viral oncogene homolog |
chrX_-_70329118 | 1.69 |
ENST00000374188.3
|
IL2RG
|
interleukin 2 receptor, gamma |
chr6_-_159466136 | 1.69 |
ENST00000367066.3
ENST00000326965.6 |
TAGAP
|
T-cell activation RhoGTPase activating protein |
chr2_-_89310012 | 1.69 |
ENST00000493819.1
|
IGKV1-9
|
immunoglobulin kappa variable 1-9 |
chr1_-_160832642 | 1.69 |
ENST00000368034.4
|
CD244
|
CD244 molecule, natural killer cell receptor 2B4 |
chr5_+_35856951 | 1.68 |
ENST00000303115.3
ENST00000343305.4 ENST00000506850.1 ENST00000511982.1 |
IL7R
|
interleukin 7 receptor |
chr19_+_16254488 | 1.68 |
ENST00000588246.1
ENST00000593031.1 |
HSH2D
|
hematopoietic SH2 domain containing |
chr6_-_130536774 | 1.67 |
ENST00000532763.1
|
SAMD3
|
sterile alpha motif domain containing 3 |
chr17_+_76126842 | 1.66 |
ENST00000590426.1
ENST00000590799.1 ENST00000318430.5 ENST00000589691.1 |
TMC8
|
transmembrane channel-like 8 |
chr2_-_192016276 | 1.66 |
ENST00000413064.1
|
STAT4
|
signal transducer and activator of transcription 4 |
chr1_-_205290865 | 1.65 |
ENST00000367157.3
|
NUAK2
|
NUAK family, SNF1-like kinase, 2 |
chr12_-_1920886 | 1.64 |
ENST00000536846.2
ENST00000538027.2 ENST00000538450.1 |
CACNA2D4
|
calcium channel, voltage-dependent, alpha 2/delta subunit 4 |
chr17_-_34625719 | 1.62 |
ENST00000422211.2
ENST00000542124.1 |
CCL3L1
|
chemokine (C-C motif) ligand 3-like 1 |
chr3_-_13461807 | 1.62 |
ENST00000254508.5
|
NUP210
|
nucleoporin 210kDa |
chr12_+_75874580 | 1.61 |
ENST00000456650.3
|
GLIPR1
|
GLI pathogenesis-related 1 |
chr17_-_29648761 | 1.61 |
ENST00000247270.3
ENST00000462804.2 |
EVI2A
|
ecotropic viral integration site 2A |
chr8_+_66955648 | 1.60 |
ENST00000522619.1
|
DNAJC5B
|
DnaJ (Hsp40) homolog, subfamily C, member 5 beta |
chr19_+_1065922 | 1.60 |
ENST00000539243.2
|
HMHA1
|
histocompatibility (minor) HA-1 |
chr8_-_143833918 | 1.59 |
ENST00000359228.3
|
LYPD2
|
LY6/PLAUR domain containing 2 |
chr22_+_50981079 | 1.59 |
ENST00000609268.1
|
CTA-384D8.34
|
CTA-384D8.34 |
chr19_+_7828035 | 1.58 |
ENST00000327325.5
ENST00000394122.2 ENST00000248228.4 ENST00000334806.5 ENST00000359059.5 ENST00000357361.2 ENST00000596363.1 ENST00000595751.1 ENST00000596707.1 ENST00000597522.1 ENST00000595496.1 |
CLEC4M
|
C-type lectin domain family 4, member M |
chr7_+_6797288 | 1.57 |
ENST00000433859.2
ENST00000359718.3 |
RSPH10B2
|
radial spoke head 10 homolog B2 (Chlamydomonas) |
chr2_+_90248739 | 1.57 |
ENST00000468879.1
|
IGKV1D-43
|
immunoglobulin kappa variable 1D-43 |
chr6_-_159466042 | 1.57 |
ENST00000338313.5
|
TAGAP
|
T-cell activation RhoGTPase activating protein |
chr14_+_22433675 | 1.57 |
ENST00000390442.3
|
TRAV12-3
|
T cell receptor alpha variable 12-3 |
chr12_-_10151773 | 1.56 |
ENST00000298527.6
ENST00000348658.4 |
CLEC1B
|
C-type lectin domain family 1, member B |
chr8_+_22435762 | 1.56 |
ENST00000456545.1
|
PDLIM2
|
PDZ and LIM domain 2 (mystique) |
chr12_-_68845165 | 1.55 |
ENST00000360485.3
ENST00000441255.2 |
RP11-81H14.2
|
RP11-81H14.2 |
chr2_+_219247021 | 1.55 |
ENST00000539932.1
|
SLC11A1
|
solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1 |
chr14_+_22520762 | 1.55 |
ENST00000390449.3
|
TRAV21
|
T cell receptor alpha variable 21 |
chr20_+_44657845 | 1.55 |
ENST00000243964.3
|
SLC12A5
|
solute carrier family 12 (potassium/chloride transporter), member 5 |
chr1_-_157670528 | 1.55 |
ENST00000368186.5
ENST00000496769.1 |
FCRL3
|
Fc receptor-like 3 |
chr5_-_131347583 | 1.51 |
ENST00000379255.1
ENST00000430403.1 ENST00000544770.1 ENST00000379246.1 ENST00000414078.1 ENST00000441995.1 |
ACSL6
|
acyl-CoA synthetase long-chain family member 6 |
chr11_-_441964 | 1.50 |
ENST00000332826.6
|
ANO9
|
anoctamin 9 |
chr14_-_106845789 | 1.49 |
ENST00000390617.2
|
IGHV3-35
|
immunoglobulin heavy variable 3-35 (non-functional) |
chr1_-_27952617 | 1.47 |
ENST00000457296.1
|
FGR
|
feline Gardner-Rasheed sarcoma viral oncogene homolog |
chr14_-_55658323 | 1.46 |
ENST00000554067.1
ENST00000247191.2 |
DLGAP5
|
discs, large (Drosophila) homolog-associated protein 5 |
chr16_+_31271274 | 1.46 |
ENST00000287497.8
ENST00000544665.3 |
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit) |
chr5_-_176936817 | 1.46 |
ENST00000502885.1
ENST00000506493.1 |
DOK3
|
docking protein 3 |
chr14_-_55658252 | 1.44 |
ENST00000395425.2
|
DLGAP5
|
discs, large (Drosophila) homolog-associated protein 5 |
chr1_-_183538319 | 1.44 |
ENST00000420553.1
ENST00000419402.1 |
NCF2
|
neutrophil cytosolic factor 2 |
chr7_-_36764004 | 1.44 |
ENST00000431169.1
|
AOAH
|
acyloxyacyl hydrolase (neutrophil) |
chr7_-_38370536 | 1.44 |
ENST00000390343.2
|
TRGV8
|
T cell receptor gamma variable 8 |
chr14_+_22694606 | 1.44 |
ENST00000390463.3
|
TRAV36DV7
|
T cell receptor alpha variable 36/delta variable 7 |
chr22_+_22781853 | 1.44 |
ENST00000390300.2
|
IGLV5-37
|
immunoglobulin lambda variable 5-37 |
chr5_-_176936844 | 1.43 |
ENST00000510380.1
ENST00000510898.1 ENST00000357198.4 |
DOK3
|
docking protein 3 |
chr7_-_142131914 | 1.43 |
ENST00000390375.2
|
TRBV5-6
|
T cell receptor beta variable 5-6 |
chr22_+_35776828 | 1.43 |
ENST00000216117.8
|
HMOX1
|
heme oxygenase (decycling) 1 |
chrX_+_37639302 | 1.42 |
ENST00000545017.1
ENST00000536160.1 |
CYBB
|
cytochrome b-245, beta polypeptide |
chrX_+_128913906 | 1.42 |
ENST00000356892.3
|
SASH3
|
SAM and SH3 domain containing 3 |
chr7_-_142149390 | 1.41 |
ENST00000390372.3
|
TRBV5-5
|
T cell receptor beta variable 5-5 |
chr19_-_17958771 | 1.41 |
ENST00000534444.1
|
JAK3
|
Janus kinase 3 |
chr14_+_22392209 | 1.41 |
ENST00000390440.2
|
TRAV14DV4
|
T cell receptor alpha variable 14/delta variable 4 |
chr12_-_7848364 | 1.41 |
ENST00000329913.3
|
GDF3
|
growth differentiation factor 3 |
chr1_-_156399184 | 1.40 |
ENST00000368243.1
ENST00000357975.4 ENST00000310027.5 ENST00000400991.2 |
C1orf61
|
chromosome 1 open reading frame 61 |
chr1_+_28199047 | 1.40 |
ENST00000373925.1
ENST00000328928.7 ENST00000373927.3 ENST00000427466.1 ENST00000442118.1 ENST00000373921.3 |
THEMIS2
|
thymocyte selection associated family member 2 |
chr6_-_32160622 | 1.40 |
ENST00000487761.1
ENST00000375040.3 |
GPSM3
|
G-protein signaling modulator 3 |
chr17_+_47296865 | 1.39 |
ENST00000573347.1
|
ABI3
|
ABI family, member 3 |
chr22_-_20231207 | 1.39 |
ENST00000425986.1
|
RTN4R
|
reticulon 4 receptor |
chr7_-_6006768 | 1.38 |
ENST00000441023.2
|
RSPH10B
|
radial spoke head 10 homolog B (Chlamydomonas) |
chr19_+_11406821 | 1.38 |
ENST00000316737.1
ENST00000592955.1 ENST00000590327.1 |
TSPAN16
|
tetraspanin 16 |
chr22_+_23089870 | 1.38 |
ENST00000390311.2
|
IGLV3-16
|
immunoglobulin lambda variable 3-16 |
chr5_-_59995921 | 1.38 |
ENST00000453022.2
ENST00000545085.1 ENST00000265036.5 |
DEPDC1B
|
DEP domain containing 1B |
chr14_-_106963409 | 1.38 |
ENST00000390621.2
|
IGHV1-45
|
immunoglobulin heavy variable 1-45 |
chr5_-_39270725 | 1.37 |
ENST00000512138.1
ENST00000512982.1 ENST00000540520.1 |
FYB
|
FYN binding protein |
chr1_+_207627697 | 1.36 |
ENST00000458541.2
|
CR2
|
complement component (3d/Epstein Barr virus) receptor 2 |
chr14_+_22465771 | 1.36 |
ENST00000390445.2
|
TRAV17
|
T cell receptor alpha variable 17 |
chr15_-_22448819 | 1.36 |
ENST00000604066.1
|
IGHV1OR15-1
|
immunoglobulin heavy variable 1/OR15-1 (non-functional) |
chr19_-_39108568 | 1.36 |
ENST00000586296.1
|
MAP4K1
|
mitogen-activated protein kinase kinase kinase kinase 1 |
chr5_-_131347306 | 1.35 |
ENST00000296869.4
ENST00000379249.3 ENST00000379272.2 ENST00000379264.2 |
ACSL6
|
acyl-CoA synthetase long-chain family member 6 |
chr5_-_49737184 | 1.35 |
ENST00000508934.1
ENST00000303221.5 |
EMB
|
embigin |
chr12_+_75874984 | 1.34 |
ENST00000550491.1
|
GLIPR1
|
GLI pathogenesis-related 1 |
chr10_+_94451574 | 1.34 |
ENST00000492654.2
|
HHEX
|
hematopoietically expressed homeobox |
chr5_-_157002775 | 1.33 |
ENST00000257527.4
|
ADAM19
|
ADAM metallopeptidase domain 19 |
chr4_-_84255935 | 1.33 |
ENST00000513463.1
|
HPSE
|
heparanase |
chr12_-_65090329 | 1.33 |
ENST00000594966.1
|
AC025262.1
|
Mesenchymal stem cell protein DSC96; Uncharacterized protein |
chr19_-_54327542 | 1.33 |
ENST00000391775.3
ENST00000324134.6 ENST00000535162.1 ENST00000351894.4 ENST00000354278.3 ENST00000391773.1 ENST00000345770.5 ENST00000391772.1 |
NLRP12
|
NLR family, pyrin domain containing 12 |
chr18_-_30353025 | 1.32 |
ENST00000359358.4
|
KLHL14
|
kelch-like family member 14 |
chr12_+_32112340 | 1.32 |
ENST00000540924.1
ENST00000312561.4 |
KIAA1551
|
KIAA1551 |
chr12_+_75874460 | 1.31 |
ENST00000266659.3
|
GLIPR1
|
GLI pathogenesis-related 1 |
chr22_+_22786288 | 1.31 |
ENST00000390301.2
|
IGLV1-36
|
immunoglobulin lambda variable 1-36 |
chr20_+_30639991 | 1.31 |
ENST00000534862.1
ENST00000538448.1 ENST00000375862.2 |
HCK
|
hemopoietic cell kinase |
chr1_+_200842083 | 1.30 |
ENST00000304244.2
|
GPR25
|
G protein-coupled receptor 25 |
chr16_-_67965756 | 1.30 |
ENST00000571044.1
ENST00000571605.1 |
CTRL
|
chymotrypsin-like |
chr4_+_78432907 | 1.30 |
ENST00000286758.4
|
CXCL13
|
chemokine (C-X-C motif) ligand 13 |
chr8_+_56014949 | 1.30 |
ENST00000327381.6
|
XKR4
|
XK, Kell blood group complex subunit-related family, member 4 |
chr12_-_6756609 | 1.29 |
ENST00000229243.2
|
ACRBP
|
acrosin binding protein |
chr8_-_73793975 | 1.29 |
ENST00000523881.1
|
RP11-1145L24.1
|
RP11-1145L24.1 |
chr6_+_167536230 | 1.29 |
ENST00000341935.5
ENST00000349984.4 |
CCR6
|
chemokine (C-C motif) receptor 6 |
chr22_+_40322595 | 1.29 |
ENST00000420971.1
ENST00000544756.1 |
GRAP2
|
GRB2-related adaptor protein 2 |
chr22_+_39493207 | 1.28 |
ENST00000348946.4
ENST00000442487.3 ENST00000421988.2 |
APOBEC3H
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3H |
chr5_+_133450365 | 1.28 |
ENST00000342854.5
ENST00000321603.6 ENST00000321584.4 ENST00000378564.1 ENST00000395029.1 |
TCF7
|
transcription factor 7 (T-cell specific, HMG-box) |
chr1_-_1142067 | 1.28 |
ENST00000379268.2
|
TNFRSF18
|
tumor necrosis factor receptor superfamily, member 18 |
chr1_+_15736359 | 1.27 |
ENST00000375980.4
|
EFHD2
|
EF-hand domain family, member D2 |
chr5_+_118604385 | 1.27 |
ENST00000274456.6
|
TNFAIP8
|
tumor necrosis factor, alpha-induced protein 8 |
chr3_-_39323155 | 1.27 |
ENST00000358309.3
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1 |
chr18_-_51884204 | 1.27 |
ENST00000577499.1
ENST00000584040.1 ENST00000581310.1 |
STARD6
|
StAR-related lipid transfer (START) domain containing 6 |
chr19_-_46526304 | 1.26 |
ENST00000008938.4
|
PGLYRP1
|
peptidoglycan recognition protein 1 |
chr6_+_36097992 | 1.26 |
ENST00000211287.4
|
MAPK13
|
mitogen-activated protein kinase 13 |
chr6_-_130182410 | 1.26 |
ENST00000368143.1
|
TMEM244
|
transmembrane protein 244 |
chr2_+_228678550 | 1.25 |
ENST00000409189.3
ENST00000358813.4 |
CCL20
|
chemokine (C-C motif) ligand 20 |
chr3_-_182880541 | 1.25 |
ENST00000470251.1
ENST00000265598.3 |
LAMP3
|
lysosomal-associated membrane protein 3 |
chr5_-_131330272 | 1.24 |
ENST00000379240.1
|
ACSL6
|
acyl-CoA synthetase long-chain family member 6 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 4.4 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
1.2 | 3.5 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
1.0 | 3.0 | GO:0040040 | thermosensory behavior(GO:0040040) |
0.9 | 3.6 | GO:0071661 | granzyme B production(GO:0071613) regulation of granzyme B production(GO:0071661) positive regulation of granzyme B production(GO:0071663) |
0.9 | 2.6 | GO:0045210 | negative regulation of dendritic cell cytokine production(GO:0002731) FasL biosynthetic process(GO:0045210) |
0.9 | 4.3 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
0.8 | 2.5 | GO:0032831 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.8 | 4.0 | GO:1904844 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
0.8 | 2.3 | GO:0055073 | cadmium ion homeostasis(GO:0055073) |
0.8 | 2.3 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) regulation of dendritic cell dendrite assembly(GO:2000547) |
0.7 | 2.9 | GO:0006788 | heme oxidation(GO:0006788) |
0.7 | 3.5 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.7 | 2.7 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
0.7 | 3.4 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.7 | 0.7 | GO:0042223 | positive regulation of interleukin-3 production(GO:0032752) interleukin-3 biosynthetic process(GO:0042223) regulation of interleukin-3 biosynthetic process(GO:0045399) positive regulation of interleukin-3 biosynthetic process(GO:0045401) |
0.6 | 1.9 | GO:0002372 | myeloid dendritic cell cytokine production(GO:0002372) |
0.6 | 1.2 | GO:0046136 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
0.6 | 1.8 | GO:0061485 | memory T cell proliferation(GO:0061485) |
0.5 | 2.7 | GO:1903284 | negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) positive regulation of peroxidase activity(GO:2000470) |
0.5 | 2.2 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.5 | 2.0 | GO:1902523 | positive regulation of protein K63-linked ubiquitination(GO:1902523) |
0.5 | 1.5 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
0.5 | 1.4 | GO:0040010 | positive regulation of growth rate(GO:0040010) regulation of gastric mucosal blood circulation(GO:1904344) positive regulation of gastric mucosal blood circulation(GO:1904346) gastric mucosal blood circulation(GO:1990768) |
0.5 | 0.5 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.5 | 1.9 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.5 | 1.4 | GO:0019858 | cytosine metabolic process(GO:0019858) |
0.4 | 1.3 | GO:0061010 | negative regulation of transcription by transcription factor localization(GO:0010621) gall bladder development(GO:0061010) |
0.4 | 2.6 | GO:0043366 | beta selection(GO:0043366) |
0.4 | 2.5 | GO:0072679 | thymocyte migration(GO:0072679) |
0.4 | 1.3 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
0.4 | 1.3 | GO:0051714 | negative regulation of natural killer cell differentiation(GO:0032824) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) positive regulation of cytolysis in other organism(GO:0051714) |
0.4 | 2.9 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
0.4 | 12.1 | GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.4 | 0.8 | GO:2000295 | regulation of hydrogen peroxide catabolic process(GO:2000295) |
0.4 | 1.2 | GO:1903461 | Okazaki fragment processing involved in mitotic DNA replication(GO:1903461) |
0.4 | 2.0 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
0.4 | 1.1 | GO:0043091 | L-arginine import(GO:0043091) arginine import(GO:0090467) |
0.4 | 1.1 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.4 | 1.1 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.4 | 0.7 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
0.4 | 1.4 | GO:0060032 | notochord regression(GO:0060032) |
0.3 | 6.3 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.3 | 0.3 | GO:0003032 | detection of oxygen(GO:0003032) |
0.3 | 2.4 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.3 | 1.7 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.3 | 2.0 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.3 | 0.7 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.3 | 1.0 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) |
0.3 | 1.3 | GO:2001027 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.3 | 4.1 | GO:0051873 | killing by host of symbiont cells(GO:0051873) |
0.3 | 0.9 | GO:0060621 | negative regulation of cholesterol import(GO:0060621) negative regulation of sterol import(GO:2000910) |
0.3 | 1.6 | GO:0046968 | peptide antigen transport(GO:0046968) |
0.3 | 4.4 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.3 | 1.8 | GO:0038112 | interleukin-8-mediated signaling pathway(GO:0038112) |
0.3 | 0.9 | GO:1902997 | regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
0.3 | 0.3 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.3 | 2.2 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
0.3 | 2.4 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.3 | 1.9 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.3 | 0.8 | GO:1904298 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) positive regulation of leukocyte tethering or rolling(GO:1903238) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
0.3 | 0.8 | GO:0021569 | rhombomere 3 development(GO:0021569) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.3 | 0.8 | GO:1903980 | positive regulation of microglial cell activation(GO:1903980) |
0.3 | 0.8 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
0.2 | 4.4 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.2 | 0.7 | GO:0001207 | histone displacement(GO:0001207) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
0.2 | 0.5 | GO:0045014 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
0.2 | 4.6 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.2 | 2.1 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.2 | 1.7 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.2 | 1.3 | GO:1903412 | response to bile acid(GO:1903412) |
0.2 | 0.6 | GO:0071140 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
0.2 | 1.0 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.2 | 4.5 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.2 | 2.2 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.2 | 0.6 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.2 | 0.6 | GO:0043132 | coenzyme A transport(GO:0015880) coenzyme A transmembrane transport(GO:0035349) NAD transport(GO:0043132) adenosine 3',5'-bisphosphate transmembrane transport(GO:0071106) AMP transport(GO:0080121) |
0.2 | 1.3 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.2 | 0.2 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.2 | 1.1 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
0.2 | 1.5 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
0.2 | 0.6 | GO:0021934 | medulla oblongata development(GO:0021550) hindbrain tangential cell migration(GO:0021934) lateral line system development(GO:0048925) |
0.2 | 4.2 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.2 | 1.3 | GO:0048619 | embryonic genitalia morphogenesis(GO:0030538) embryonic hindgut morphogenesis(GO:0048619) |
0.2 | 0.2 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.2 | 0.9 | GO:1990523 | bone regeneration(GO:1990523) |
0.2 | 1.1 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.2 | 0.7 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.2 | 2.3 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.2 | 1.9 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.2 | 1.6 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.2 | 14.2 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.2 | 0.9 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.2 | 0.3 | GO:0043311 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
0.2 | 1.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.2 | 1.2 | GO:0051510 | regulation of unidimensional cell growth(GO:0051510) negative regulation of unidimensional cell growth(GO:0051511) establishment of cell polarity regulating cell shape(GO:0071964) regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) regulation of establishment of cell polarity regulating cell shape(GO:2000782) positive regulation of establishment of cell polarity regulating cell shape(GO:2000784) positive regulation of barbed-end actin filament capping(GO:2000814) |
0.2 | 0.7 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.2 | 1.2 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.2 | 0.5 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.2 | 1.1 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.2 | 0.7 | GO:0032571 | response to vitamin K(GO:0032571) |
0.2 | 0.5 | GO:0008057 | eye pigment granule organization(GO:0008057) |
0.2 | 3.4 | GO:0045730 | respiratory burst(GO:0045730) |
0.2 | 0.6 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
0.2 | 0.9 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.2 | 1.4 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.2 | 1.1 | GO:0071315 | cellular response to morphine(GO:0071315) cellular response to isoquinoline alkaloid(GO:0071317) |
0.2 | 0.3 | GO:0021764 | amygdala development(GO:0021764) |
0.2 | 0.9 | GO:0044805 | late nucleophagy(GO:0044805) |
0.2 | 0.6 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.2 | 1.2 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.2 | 3.3 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.2 | 1.8 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.2 | 1.5 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.1 | 0.4 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.1 | 0.6 | GO:2001162 | regulation of histone H3-K79 methylation(GO:2001160) positive regulation of histone H3-K79 methylation(GO:2001162) |
0.1 | 0.4 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.1 | 0.4 | GO:1902303 | regulation of heart rate by hormone(GO:0003064) negative regulation of potassium ion export(GO:1902303) |
0.1 | 1.0 | GO:0071461 | cellular response to redox state(GO:0071461) |
0.1 | 5.4 | GO:0097186 | amelogenesis(GO:0097186) |
0.1 | 1.1 | GO:0050893 | sensory processing(GO:0050893) |
0.1 | 0.5 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.1 | 1.1 | GO:0044146 | negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.1 | 2.4 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 2.9 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.1 | 0.5 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
0.1 | 1.1 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 2.2 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.1 | 0.4 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
0.1 | 0.7 | GO:0007343 | egg activation(GO:0007343) |
0.1 | 1.0 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.1 | 1.8 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.1 | 0.6 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.1 | 0.8 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.1 | 1.6 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 3.2 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.1 | 0.4 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.1 | 1.2 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.1 | 0.2 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.1 | 0.6 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.1 | 0.8 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.1 | 0.6 | GO:0009107 | lipoate biosynthetic process(GO:0009107) |
0.1 | 0.4 | GO:0042938 | dipeptide transport(GO:0042938) |
0.1 | 5.0 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
0.1 | 0.5 | GO:0032690 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
0.1 | 0.4 | GO:1903568 | negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
0.1 | 2.0 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.1 | 0.5 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.1 | 5.3 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.1 | 0.5 | GO:0038124 | toll-like receptor TLR6:TLR2 signaling pathway(GO:0038124) response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
0.1 | 0.5 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
0.1 | 13.5 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 0.8 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.1 | 1.2 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
0.1 | 1.1 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.1 | 0.5 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.1 | 0.4 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 1.1 | GO:2000371 | regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
0.1 | 0.6 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
0.1 | 0.6 | GO:0021633 | optic nerve structural organization(GO:0021633) |
0.1 | 0.3 | GO:1990637 | response to prolactin(GO:1990637) |
0.1 | 1.6 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
0.1 | 0.5 | GO:0045976 | negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
0.1 | 0.2 | GO:1901228 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
0.1 | 0.3 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
0.1 | 0.8 | GO:1901189 | positive regulation of ephrin receptor signaling pathway(GO:1901189) positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
0.1 | 0.3 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.1 | 1.1 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.1 | 0.4 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.1 | 2.6 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 1.0 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.1 | 0.8 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.1 | 4.4 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 0.2 | GO:0071335 | submandibular salivary gland formation(GO:0060661) hair follicle cell proliferation(GO:0071335) regulation of hair follicle cell proliferation(GO:0071336) positive regulation of hair follicle cell proliferation(GO:0071338) |
0.1 | 1.9 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.1 | 0.9 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 3.0 | GO:0045066 | regulatory T cell differentiation(GO:0045066) regulation of regulatory T cell differentiation(GO:0045589) |
0.1 | 0.5 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
0.1 | 0.3 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.1 | 1.4 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.1 | 0.2 | GO:0035038 | female pronucleus assembly(GO:0035038) |
0.1 | 0.5 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.1 | 1.1 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.1 | 6.0 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.1 | 1.4 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.1 | 1.2 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.3 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.1 | 0.5 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.1 | 0.3 | GO:0019516 | lactate oxidation(GO:0019516) |
0.1 | 0.5 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.4 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
0.1 | 0.3 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.1 | 0.6 | GO:0036101 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
0.1 | 0.3 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
0.1 | 0.3 | GO:0090222 | centrosome-templated microtubule nucleation(GO:0090222) |
0.1 | 0.1 | GO:1903433 | regulation of constitutive secretory pathway(GO:1903433) |
0.1 | 0.9 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.1 | 0.6 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.1 | 0.4 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
0.1 | 0.3 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
0.1 | 0.9 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.1 | 0.3 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.1 | 0.6 | GO:0031438 | negative regulation of mRNA cleavage(GO:0031438) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
0.1 | 0.3 | GO:0031647 | regulation of protein stability(GO:0031647) |
0.1 | 0.4 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.1 | 0.6 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) |
0.1 | 0.3 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.1 | 0.9 | GO:0007127 | meiosis I(GO:0007127) |
0.1 | 1.2 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.6 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.1 | 0.4 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 0.5 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.1 | 1.5 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.1 | 0.7 | GO:0015755 | fructose transport(GO:0015755) |
0.1 | 0.7 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.1 | 0.2 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.1 | 0.7 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.1 | 0.2 | GO:1903925 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) negative regulation of mitotic cell cycle DNA replication(GO:1903464) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
0.1 | 5.9 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.2 | GO:2001280 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.1 | 0.6 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.1 | 0.2 | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
0.1 | 0.6 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 0.5 | GO:1904970 | brush border assembly(GO:1904970) |
0.1 | 1.4 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.1 | 0.4 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.1 | 0.2 | GO:0035655 | interleukin-18-mediated signaling pathway(GO:0035655) |
0.1 | 0.4 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.1 | 2.5 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 2.0 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.1 | 0.5 | GO:1901162 | primary amino compound biosynthetic process(GO:1901162) |
0.1 | 1.5 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 0.5 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 1.1 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.1 | 0.2 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.1 | 1.9 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.1 | 3.9 | GO:0033198 | response to ATP(GO:0033198) |
0.1 | 0.9 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 1.8 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.4 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.1 | 0.3 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.1 | 0.8 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.1 | 0.4 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
0.1 | 6.9 | GO:0042100 | B cell proliferation(GO:0042100) |
0.1 | 0.8 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.1 | 1.0 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.1 | 1.0 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.1 | 1.1 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 12.0 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.1 | 1.7 | GO:0051197 | positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.1 | 1.4 | GO:0030177 | positive regulation of Wnt signaling pathway(GO:0030177) |
0.1 | 0.8 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 0.9 | GO:0030238 | male sex determination(GO:0030238) |
0.1 | 1.5 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.1 | 0.9 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.9 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.1 | 0.1 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.1 | 0.3 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.1 | 0.2 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.1 | 0.4 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
0.1 | 1.2 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 1.0 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.1 | 0.8 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
0.1 | 0.2 | GO:0034204 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.1 | 2.0 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.1 | 0.5 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.1 | 0.3 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
0.1 | 0.3 | GO:0007340 | acrosome reaction(GO:0007340) |
0.1 | 0.6 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.1 | 0.1 | GO:0002447 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil activation(GO:0043307) eosinophil degranulation(GO:0043308) |
0.1 | 0.2 | GO:1904585 | response to putrescine(GO:1904585) cellular response to putrescine(GO:1904586) hepatocyte dedifferentiation(GO:1990828) |
0.1 | 0.5 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.1 | 0.3 | GO:1990569 | UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
0.1 | 1.0 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.3 | GO:0002645 | positive regulation of tolerance induction(GO:0002645) |
0.1 | 0.3 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) |
0.1 | 0.1 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.1 | 0.4 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.1 | 1.4 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 1.3 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.1 | 0.1 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.1 | 0.1 | GO:0007412 | axon target recognition(GO:0007412) |
0.1 | 0.8 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.1 | 0.5 | GO:0007422 | peripheral nervous system development(GO:0007422) |
0.1 | 0.8 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.1 | 2.5 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 2.1 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.1 | 0.2 | GO:1904798 | positive regulation of core promoter binding(GO:1904798) |
0.1 | 0.2 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
0.1 | 0.2 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.1 | 0.3 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
0.1 | 0.3 | GO:0045667 | regulation of osteoblast differentiation(GO:0045667) |
0.1 | 1.0 | GO:0051321 | meiotic cell cycle(GO:0051321) |
0.1 | 0.6 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
0.1 | 0.1 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
0.1 | 0.3 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
0.1 | 0.1 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
0.1 | 0.6 | GO:0015850 | organic hydroxy compound transport(GO:0015850) |
0.1 | 0.4 | GO:0002353 | kinin cascade(GO:0002254) plasma kallikrein-kinin cascade(GO:0002353) |
0.1 | 4.2 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.1 | 0.3 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
0.1 | 0.6 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.1 | 0.4 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
0.1 | 0.4 | GO:1900239 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
0.1 | 1.7 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.1 | GO:0051097 | negative regulation of helicase activity(GO:0051097) oligodendrocyte apoptotic process(GO:0097252) |
0.1 | 2.3 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.1 | 0.7 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.1 | 0.4 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.1 | 0.8 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.1 | 0.2 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.1 | 0.3 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 0.4 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.1 | 1.1 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 1.9 | GO:0030431 | sleep(GO:0030431) |
0.1 | 1.4 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.2 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 1.6 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.3 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.0 | 0.1 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.0 | 2.0 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.0 | 0.0 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.0 | 1.1 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.0 | 0.5 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
0.0 | 0.3 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.0 | 0.7 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.0 | 0.3 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.0 | 0.2 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.0 | 1.3 | GO:0050856 | regulation of T cell receptor signaling pathway(GO:0050856) |
0.0 | 0.2 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.0 | 0.2 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.0 | 1.0 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.1 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.0 | 0.4 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.0 | 0.6 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.1 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
0.0 | 0.4 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.0 | 0.1 | GO:0009443 | pyridoxal 5'-phosphate salvage(GO:0009443) |
0.0 | 0.3 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.0 | 1.6 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
0.0 | 0.3 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.0 | 2.1 | GO:1900077 | negative regulation of insulin receptor signaling pathway(GO:0046627) negative regulation of cellular response to insulin stimulus(GO:1900077) |
0.0 | 0.8 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.2 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
0.0 | 1.1 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.0 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 0.2 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.0 | 0.3 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
0.0 | 1.3 | GO:0007140 | male meiosis(GO:0007140) |
0.0 | 0.2 | GO:2000403 | positive regulation of lymphocyte migration(GO:2000403) |
0.0 | 1.9 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.0 | 0.8 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
0.0 | 0.1 | GO:0033320 | UDP-D-xylose metabolic process(GO:0033319) UDP-D-xylose biosynthetic process(GO:0033320) |
0.0 | 0.7 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.5 | GO:0060872 | semicircular canal development(GO:0060872) |
0.0 | 0.4 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.0 | 0.2 | GO:0009224 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
0.0 | 0.7 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.0 | 0.8 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.0 | 0.3 | GO:0072092 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
0.0 | 0.6 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.0 | 1.7 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.0 | 0.8 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.0 | 0.3 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.0 | 0.5 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.0 | 0.5 | GO:0001763 | morphogenesis of a branching structure(GO:0001763) |
0.0 | 0.4 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.0 | 0.6 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.0 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.0 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
0.0 | 0.7 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.0 | 0.6 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.0 | 0.5 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
0.0 | 1.0 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.1 | GO:0007057 | spindle assembly involved in female meiosis I(GO:0007057) |
0.0 | 0.1 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
0.0 | 3.7 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.0 | 0.2 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.0 | 0.1 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.0 | 0.1 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.0 | 0.3 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.0 | 1.5 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 0.3 | GO:1903416 | response to glycoside(GO:1903416) |
0.0 | 0.2 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.0 | 0.4 | GO:0050951 | sensory perception of temperature stimulus(GO:0050951) |
0.0 | 0.6 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.0 | 0.2 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.0 | 0.3 | GO:0008228 | opsonization(GO:0008228) |
0.0 | 0.2 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.0 | 0.1 | GO:0002384 | hepatic immune response(GO:0002384) |
0.0 | 0.1 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.0 | 0.1 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
0.0 | 0.2 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.0 | 0.4 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.0 | 0.3 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.0 | 0.2 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.0 | 1.9 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.0 | 0.7 | GO:0043584 | nose development(GO:0043584) |
0.0 | 0.1 | GO:0000494 | box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
0.0 | 0.4 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
0.0 | 0.4 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 0.1 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.0 | 0.3 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.0 | 0.3 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.0 | 0.1 | GO:0016267 | O-glycan processing, core 1(GO:0016267) |
0.0 | 1.5 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.0 | 0.7 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.0 | 0.7 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.0 | 0.1 | GO:0030187 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.0 | 0.5 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 0.1 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.0 | 1.4 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.0 | 0.3 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.0 | 0.4 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.0 | 0.1 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
0.0 | 0.2 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
0.0 | 0.5 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.0 | 0.7 | GO:0030220 | platelet formation(GO:0030220) platelet morphogenesis(GO:0036344) |
0.0 | 0.1 | GO:0021650 | vestibulocochlear nerve morphogenesis(GO:0021648) vestibulocochlear nerve formation(GO:0021650) |
0.0 | 0.3 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.0 | 0.3 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.0 | 1.0 | GO:0015695 | organic cation transport(GO:0015695) |
0.0 | 0.3 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.0 | 0.2 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.0 | 0.2 | GO:0071902 | positive regulation of protein serine/threonine kinase activity(GO:0071902) |
0.0 | 1.2 | GO:0046710 | GDP metabolic process(GO:0046710) |
0.0 | 0.4 | GO:0090266 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.0 | 0.2 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.0 | 0.3 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.0 | 0.5 | GO:1901748 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.0 | 1.2 | GO:0003341 | cilium movement(GO:0003341) |
0.0 | 1.7 | GO:0030183 | B cell differentiation(GO:0030183) |
0.0 | 0.8 | GO:0090307 | mitotic spindle assembly(GO:0090307) |
0.0 | 0.4 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.0 | 0.2 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.0 | 0.2 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.0 | 0.8 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.2 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.0 | 0.1 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.0 | 0.9 | GO:0043303 | mast cell activation involved in immune response(GO:0002279) mast cell degranulation(GO:0043303) |
0.0 | 2.5 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.0 | 0.3 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.0 | 0.1 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.0 | 0.2 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) |
0.0 | 0.0 | GO:0006071 | glycerol metabolic process(GO:0006071) alditol metabolic process(GO:0019400) |
0.0 | 0.2 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.0 | 0.9 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.0 | 0.4 | GO:0016337 | single organismal cell-cell adhesion(GO:0016337) |
0.0 | 0.5 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.0 | 0.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.0 | 0.3 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.0 | 0.2 | GO:1903826 | arginine transmembrane transport(GO:1903826) |
0.0 | 0.6 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.0 | 0.2 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.0 | 0.2 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.0 | 0.1 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.0 | 1.5 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.3 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 2.6 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.0 | 0.7 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.0 | 0.2 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.2 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.0 | 0.2 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.5 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.2 | GO:0050711 | negative regulation of interleukin-1 secretion(GO:0050711) |
0.0 | 0.5 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.0 | 0.1 | GO:0009914 | hormone transport(GO:0009914) |
0.0 | 0.4 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.0 | 1.2 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.0 | 0.3 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.0 | 3.9 | GO:0002250 | adaptive immune response(GO:0002250) |
0.0 | 0.4 | GO:0002021 | response to dietary excess(GO:0002021) |
0.0 | 0.4 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.0 | 0.4 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.0 | 0.7 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.0 | 0.3 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.0 | 0.1 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.0 | 0.2 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
0.0 | 0.2 | GO:0009227 | UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
0.0 | 0.1 | GO:0032479 | regulation of type I interferon production(GO:0032479) type I interferon production(GO:0032606) |
0.0 | 0.1 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.0 | 0.3 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.2 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.0 | 0.2 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.0 | 0.4 | GO:0090305 | nucleic acid phosphodiester bond hydrolysis(GO:0090305) |
0.0 | 0.3 | GO:0032098 | regulation of appetite(GO:0032098) |
0.0 | 0.7 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 0.1 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.0 | 0.5 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.0 | 0.1 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.0 | 0.1 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.0 | 0.4 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.0 | 0.1 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.0 | 0.1 | GO:1903351 | response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
0.0 | 0.3 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.0 | 0.4 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.2 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.0 | 0.1 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
0.0 | 0.1 | GO:0071027 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.0 | 0.2 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.0 | 0.3 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
0.0 | 0.4 | GO:0048536 | spleen development(GO:0048536) |
0.0 | 2.0 | GO:0007259 | JAK-STAT cascade(GO:0007259) STAT cascade(GO:0097696) |
0.0 | 0.1 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 0.5 | GO:0050715 | positive regulation of cytokine secretion(GO:0050715) |
0.0 | 0.4 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.0 | 1.2 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.0 | 0.1 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.0 | 0.1 | GO:0070846 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
0.0 | 0.1 | GO:0046599 | floor plate development(GO:0033504) regulation of centriole replication(GO:0046599) |
0.0 | 0.2 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.0 | 0.1 | GO:0015822 | mitochondrial ornithine transport(GO:0000066) ornithine transport(GO:0015822) |
0.0 | 1.5 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.0 | 0.2 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
0.0 | 0.4 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.0 | 0.1 | GO:0060674 | placenta blood vessel development(GO:0060674) labyrinthine layer blood vessel development(GO:0060716) |
0.0 | 0.1 | GO:0050803 | regulation of synapse structure or activity(GO:0050803) |
0.0 | 0.0 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
0.0 | 0.1 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.0 | 0.2 | GO:0090179 | planar cell polarity pathway involved in neural tube closure(GO:0090179) |
0.0 | 0.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.7 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.0 | 0.1 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
0.0 | 0.1 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.0 | 0.1 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.0 | 0.5 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
0.0 | 0.4 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.0 | 0.1 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.0 | 0.6 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.0 | 0.0 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.0 | 0.1 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.1 | GO:0014850 | response to muscle activity(GO:0014850) |
0.0 | 0.2 | GO:0033046 | negative regulation of sister chromatid segregation(GO:0033046) negative regulation of mitotic sister chromatid segregation(GO:0033048) negative regulation of chromosome segregation(GO:0051985) negative regulation of mitotic sister chromatid separation(GO:2000816) |
0.0 | 0.1 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.2 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
0.0 | 0.7 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.0 | 0.0 | GO:0014908 | myotube differentiation involved in skeletal muscle regeneration(GO:0014908) |
0.0 | 0.1 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.0 | 0.1 | GO:0034214 | protein hexamerization(GO:0034214) |
0.0 | 0.1 | GO:1990502 | dense core granule maturation(GO:1990502) |
0.0 | 0.2 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.0 | 0.4 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.0 | 0.0 | GO:0051086 | chaperone mediated protein folding independent of cofactor(GO:0051086) |
0.0 | 0.3 | GO:0006825 | copper ion transport(GO:0006825) |
0.0 | 0.2 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.0 | 0.0 | GO:0001188 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
0.0 | 0.1 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.0 | 0.1 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.8 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.5 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.0 | 0.2 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.0 | 0.8 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.0 | 0.5 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.0 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.0 | 0.2 | GO:0006955 | immune response(GO:0006955) |
0.0 | 0.1 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
0.0 | 0.2 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.0 | 0.4 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.0 | GO:0014065 | phosphatidylinositol 3-kinase signaling(GO:0014065) |
0.0 | 0.4 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.0 | 0.1 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.0 | 0.0 | GO:0032773 | regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
0.0 | 0.1 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 2.8 | GO:0071748 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
0.9 | 4.3 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
0.7 | 5.5 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
0.5 | 1.5 | GO:0032173 | septin ring(GO:0005940) septin collar(GO:0032173) |
0.4 | 1.3 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.4 | 4.5 | GO:0097486 | multivesicular body lumen(GO:0097486) |
0.3 | 2.1 | GO:0097441 | basilar dendrite(GO:0097441) |
0.3 | 3.4 | GO:0032010 | phagolysosome(GO:0032010) |
0.3 | 2.1 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.3 | 15.2 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.3 | 0.9 | GO:0032783 | ELL-EAF complex(GO:0032783) |
0.3 | 1.4 | GO:0036156 | inner dynein arm(GO:0036156) |
0.3 | 1.1 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
0.3 | 1.1 | GO:0097232 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
0.3 | 4.0 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.2 | 1.2 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
0.2 | 1.8 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.2 | 1.5 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.2 | 0.8 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.2 | 0.8 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.2 | 1.3 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
0.2 | 2.7 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.2 | 0.5 | GO:0036117 | hyaluranon cable(GO:0036117) |
0.2 | 0.9 | GO:1990031 | pinceau fiber(GO:1990031) |
0.2 | 1.9 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.2 | 1.5 | GO:0035976 | AP1 complex(GO:0035976) |
0.2 | 12.5 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 2.9 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.2 | 0.5 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 1.2 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.1 | 2.2 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 2.4 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.4 | GO:0097447 | dendritic tree(GO:0097447) |
0.1 | 1.8 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.5 | GO:0036284 | tubulobulbar complex(GO:0036284) |
0.1 | 0.5 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 0.1 | GO:0044292 | dendrite terminus(GO:0044292) dendritic growth cone(GO:0044294) |
0.1 | 11.7 | GO:0035580 | specific granule lumen(GO:0035580) |
0.1 | 5.1 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.1 | 0.7 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.1 | 3.9 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.1 | 1.9 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 4.8 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 2.1 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 4.2 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.1 | 3.2 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.1 | 1.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 1.3 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 0.8 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 0.7 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
0.1 | 0.5 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 2.1 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.1 | 0.1 | GO:0000243 | commitment complex(GO:0000243) |
0.1 | 0.4 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.1 | 1.4 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.3 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 0.8 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 0.9 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 0.6 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.1 | 2.1 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 0.6 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.7 | GO:0042025 | host cell nucleus(GO:0042025) |
0.1 | 1.0 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 7.8 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.1 | 0.4 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.1 | 1.3 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 1.2 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 4.5 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.2 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 15.2 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 0.1 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.1 | 0.2 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.1 | 0.3 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.1 | 0.3 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.1 | 0.3 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.1 | 0.3 | GO:0034753 | nuclear aryl hydrocarbon receptor complex(GO:0034753) |
0.1 | 0.5 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.9 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.6 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 0.2 | GO:0001534 | radial spoke(GO:0001534) |
0.1 | 2.1 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 7.1 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.1 | 1.2 | GO:0000800 | lateral element(GO:0000800) |
0.1 | 0.6 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 0.9 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.0 | 0.5 | GO:0005638 | lamin filament(GO:0005638) |
0.0 | 0.6 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.0 | 4.6 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 1.5 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.0 | 0.3 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.0 | 1.1 | GO:0001741 | XY body(GO:0001741) |
0.0 | 0.5 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.0 | 0.9 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.0 | 0.5 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.9 | GO:0000812 | Swr1 complex(GO:0000812) |
0.0 | 0.6 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 0.7 | GO:0032433 | filopodium tip(GO:0032433) |
0.0 | 1.5 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 0.8 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.4 | GO:0005901 | caveola(GO:0005901) |
0.0 | 0.4 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 0.7 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.0 | 0.3 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.0 | 3.4 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.0 | 0.3 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.0 | 0.5 | GO:0097708 | cytoplasmic vesicle(GO:0031410) intracellular vesicle(GO:0097708) |
0.0 | 0.1 | GO:0000811 | GINS complex(GO:0000811) |
0.0 | 0.5 | GO:0033269 | internode region of axon(GO:0033269) |
0.0 | 1.8 | GO:0000791 | euchromatin(GO:0000791) |
0.0 | 2.0 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.0 | 0.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.2 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.0 | 0.9 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 0.2 | GO:0005694 | chromosome(GO:0005694) |
0.0 | 0.1 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
0.0 | 0.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 0.1 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.0 | 0.8 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 0.5 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.3 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 1.2 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.0 | 0.3 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 9.0 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.3 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.0 | 2.2 | GO:0043657 | host(GO:0018995) host cell(GO:0043657) |
0.0 | 0.1 | GO:0016935 | glycine-gated chloride channel complex(GO:0016935) |
0.0 | 0.3 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.0 | 1.0 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.7 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.0 | 0.1 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.0 | 0.2 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.0 | 1.2 | GO:0000786 | nucleosome(GO:0000786) |
0.0 | 0.1 | GO:0005668 | RNA polymerase transcription factor SL1 complex(GO:0005668) |
0.0 | 0.1 | GO:0035101 | FACT complex(GO:0035101) |
0.0 | 0.3 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 0.4 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.0 | 0.6 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.5 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 1.2 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.0 | 0.2 | GO:0031415 | NatA complex(GO:0031415) |
0.0 | 0.3 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.2 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.0 | 2.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 0.6 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 0.4 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.5 | GO:0032590 | dendrite membrane(GO:0032590) |
0.0 | 0.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.2 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.0 | 1.2 | GO:0005876 | spindle microtubule(GO:0005876) |
0.0 | 0.3 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 0.3 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.0 | 2.4 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 1.0 | GO:0035861 | site of double-strand break(GO:0035861) |
0.0 | 4.4 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.0 | 0.2 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 0.5 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.0 | 0.4 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.0 | 1.4 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.0 | 2.9 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 1.0 | GO:0097542 | ciliary tip(GO:0097542) |
0.0 | 0.5 | GO:0042627 | chylomicron(GO:0042627) |
0.0 | 0.4 | GO:0031105 | septin complex(GO:0031105) |
0.0 | 0.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.0 | 0.2 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.7 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.0 | 0.6 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.0 | 0.3 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.2 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.0 | 2.1 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.1 | GO:0032021 | NELF complex(GO:0032021) |
0.0 | 0.8 | GO:0035579 | specific granule membrane(GO:0035579) |
0.0 | 0.2 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.2 | GO:0036038 | MKS complex(GO:0036038) |
0.0 | 0.3 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.1 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.0 | 1.2 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 1.4 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.0 | 1.0 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.1 | GO:0070652 | HAUS complex(GO:0070652) |
0.0 | 0.5 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 0.4 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 0.0 | GO:1990393 | 3M complex(GO:1990393) |
0.0 | 3.9 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.0 | 0.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 5.7 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
0.9 | 3.6 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
0.8 | 3.4 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
0.8 | 2.3 | GO:0051139 | metal ion:proton antiporter activity(GO:0051139) |
0.7 | 2.9 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.6 | 1.9 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.6 | 2.4 | GO:0030305 | beta-glucuronidase activity(GO:0004566) heparanase activity(GO:0030305) |
0.6 | 4.1 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.6 | 2.8 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.5 | 2.7 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
0.5 | 1.4 | GO:0031768 | ghrelin receptor binding(GO:0031768) |
0.5 | 5.6 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
0.5 | 0.5 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.5 | 4.2 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.5 | 1.4 | GO:0038131 | neuregulin receptor activity(GO:0038131) |
0.5 | 2.7 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.5 | 0.5 | GO:0001855 | complement component C4b binding(GO:0001855) |
0.4 | 1.3 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
0.4 | 1.7 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.4 | 1.3 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
0.4 | 1.2 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
0.4 | 3.5 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.4 | 1.2 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.4 | 3.4 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.4 | 3.7 | GO:0019863 | IgE binding(GO:0019863) |
0.4 | 1.1 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
0.4 | 1.1 | GO:0015633 | zinc transporting ATPase activity(GO:0015633) |
0.4 | 2.8 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.3 | 1.0 | GO:0050135 | NAD(P)+ nucleosidase activity(GO:0050135) |
0.3 | 1.0 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
0.3 | 1.3 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.3 | 1.3 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
0.3 | 1.2 | GO:0031811 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
0.3 | 1.8 | GO:0004918 | interleukin-8 receptor activity(GO:0004918) |
0.3 | 7.4 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.3 | 17.1 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.3 | 1.2 | GO:0036134 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
0.3 | 0.9 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.3 | 1.0 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.3 | 0.5 | GO:0072341 | modified amino acid binding(GO:0072341) |
0.2 | 5.2 | GO:0005542 | folic acid binding(GO:0005542) |
0.2 | 1.5 | GO:0001851 | complement component C3b binding(GO:0001851) |
0.2 | 0.7 | GO:0031531 | thyrotropin-releasing hormone receptor binding(GO:0031531) |
0.2 | 0.9 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.2 | 3.0 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.2 | 0.4 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.2 | 1.8 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.2 | 0.6 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
0.2 | 3.6 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.2 | 1.9 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.2 | 0.6 | GO:0097259 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
0.2 | 0.8 | GO:0004802 | transketolase activity(GO:0004802) |
0.2 | 6.8 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 0.6 | GO:0080122 | coenzyme A transmembrane transporter activity(GO:0015228) adenosine 3',5'-bisphosphate transmembrane transporter activity(GO:0071077) AMP transmembrane transporter activity(GO:0080122) |
0.2 | 0.6 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.2 | 2.4 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.2 | 1.8 | GO:0030884 | lipid antigen binding(GO:0030882) endogenous lipid antigen binding(GO:0030883) exogenous lipid antigen binding(GO:0030884) |
0.2 | 0.9 | GO:0042806 | fucose binding(GO:0042806) |
0.2 | 0.9 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.2 | 4.8 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.2 | 0.9 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.2 | 1.9 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.2 | 1.0 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.2 | 1.2 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.2 | 0.7 | GO:0048030 | disaccharide binding(GO:0048030) |
0.2 | 0.7 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 0.8 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
0.2 | 1.9 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.2 | 0.6 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
0.2 | 0.5 | GO:0001847 | opsonin receptor activity(GO:0001847) |
0.2 | 1.5 | GO:0099529 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
0.1 | 23.5 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 1.0 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.1 | 0.9 | GO:0052828 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
0.1 | 29.4 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 0.4 | GO:0071633 | dihydroceramidase activity(GO:0071633) |
0.1 | 0.8 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.1 | 1.8 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.1 | 0.5 | GO:0038047 | beta-endorphin receptor activity(GO:0004979) morphine receptor activity(GO:0038047) |
0.1 | 2.0 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.1 | 0.8 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 1.5 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.4 | GO:0015322 | proton-dependent oligopeptide secondary active transmembrane transporter activity(GO:0005427) secondary active oligopeptide transmembrane transporter activity(GO:0015322) |
0.1 | 0.5 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 2.5 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 0.8 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
0.1 | 0.8 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.1 | 2.6 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 1.2 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 0.4 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.1 | 0.5 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.9 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.1 | 2.9 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 0.8 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 0.9 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.7 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.1 | 0.4 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.1 | 2.2 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.1 | 8.3 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.8 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 0.7 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.5 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.1 | 0.5 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.1 | 0.4 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.1 | 5.3 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.6 | GO:0050436 | microfibril binding(GO:0050436) |
0.1 | 0.5 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.1 | 0.6 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.1 | 2.5 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.5 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.1 | 1.5 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 2.6 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.6 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.1 | 1.2 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
0.1 | 0.3 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.1 | 1.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 1.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 0.3 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.1 | 2.7 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 3.6 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.3 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.1 | 1.7 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.1 | 0.6 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 2.6 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.1 | 1.7 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 1.4 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.5 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.1 | 0.4 | GO:0051120 | hepoxilin A3 synthase activity(GO:0051120) |
0.1 | 0.9 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.1 | 0.7 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
0.1 | 0.4 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 0.6 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.1 | 0.8 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.6 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.1 | 0.9 | GO:0004875 | complement receptor activity(GO:0004875) |
0.1 | 1.2 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 1.5 | GO:0000150 | recombinase activity(GO:0000150) |
0.1 | 0.7 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 0.3 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.1 | 0.5 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 2.2 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 0.4 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.1 | 0.9 | GO:0042287 | MHC protein binding(GO:0042287) |
0.1 | 0.9 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 2.8 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 1.5 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 2.0 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.1 | 0.5 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.3 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
0.1 | 0.3 | GO:0005462 | UDP-N-acetylglucosamine transmembrane transporter activity(GO:0005462) |
0.1 | 0.2 | GO:0005549 | odorant binding(GO:0005549) |
0.1 | 0.2 | GO:0050254 | rhodopsin kinase activity(GO:0050254) |
0.1 | 0.4 | GO:0008955 | peptidoglycan glycosyltransferase activity(GO:0008955) |
0.1 | 1.9 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 0.2 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.1 | 0.2 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
0.1 | 0.5 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.1 | 0.9 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.1 | 0.4 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 1.4 | GO:0010857 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) calcium-dependent protein kinase activity(GO:0010857) |
0.1 | 1.3 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 0.5 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.1 | 0.8 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.1 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.1 | 0.5 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.1 | 1.2 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 1.8 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 1.9 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.9 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.2 | GO:0035034 | histone acetyltransferase regulator activity(GO:0035034) |
0.1 | 0.3 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.1 | 0.8 | GO:0016594 | glycine binding(GO:0016594) |
0.1 | 0.3 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 0.4 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.1 | 1.8 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 1.6 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.3 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.0 | 0.1 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.0 | 0.2 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.0 | 1.7 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.0 | 0.7 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.0 | 0.1 | GO:0004961 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
0.0 | 1.8 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 2.3 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 0.1 | GO:0008478 | pyridoxal kinase activity(GO:0008478) |
0.0 | 0.6 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.1 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.0 | 0.6 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.0 | 0.3 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
0.0 | 1.6 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 1.9 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.1 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
0.0 | 0.2 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
0.0 | 0.1 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.0 | 0.1 | GO:0048040 | UDP-glucuronate decarboxylase activity(GO:0048040) |
0.0 | 1.7 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 2.3 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.0 | 1.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.9 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.1 | GO:0004560 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
0.0 | 0.7 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.9 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.0 | GO:0030617 | transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity(GO:0030617) |
0.0 | 0.3 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.0 | 0.9 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.0 | 0.6 | GO:0031702 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
0.0 | 1.2 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 1.8 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.0 | 0.3 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.0 | 0.5 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.0 | 1.6 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.3 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.0 | 0.3 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
0.0 | 0.1 | GO:0070119 | ciliary neurotrophic factor binding(GO:0070119) |
0.0 | 1.2 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.1 | GO:0005497 | androgen binding(GO:0005497) |
0.0 | 0.4 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.0 | 0.8 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.0 | GO:0009383 | C-methyltransferase activity(GO:0008169) rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
0.0 | 0.2 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
0.0 | 0.1 | GO:0036009 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
0.0 | 0.4 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.0 | 0.2 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.0 | 0.2 | GO:1990450 | linear polyubiquitin binding(GO:1990450) |
0.0 | 0.1 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.0 | 0.1 | GO:0016263 | glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity(GO:0016263) |
0.0 | 1.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.2 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.0 | 1.5 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.1 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
0.0 | 0.3 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.0 | 1.8 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.0 | 0.3 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.0 | 0.2 | GO:0005119 | smoothened binding(GO:0005119) |
0.0 | 0.3 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.0 | 0.3 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.9 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 1.3 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.1 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.0 | 0.2 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.1 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
0.0 | 0.7 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.4 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.1 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.0 | 1.0 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.5 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.0 | 0.9 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.0 | 0.6 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.0 | 0.4 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 1.1 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.2 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.0 | 0.2 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.0 | 0.1 | GO:0004040 | amidase activity(GO:0004040) glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.0 | 0.2 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 1.1 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.1 | GO:0031877 | somatostatin receptor binding(GO:0031877) |
0.0 | 2.2 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.3 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 1.5 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 0.2 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.0 | 0.3 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.0 | 0.1 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.0 | 0.3 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 0.9 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 2.6 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.3 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.0 | 0.1 | GO:0004510 | tryptophan 5-monooxygenase activity(GO:0004510) |
0.0 | 1.2 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.2 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.0 | 0.2 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.0 | 0.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.2 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.0 | 0.2 | GO:0043515 | kinetochore binding(GO:0043515) |
0.0 | 0.1 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
0.0 | 0.1 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.0 | 0.5 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.2 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.2 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.3 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.3 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.4 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.0 | 1.4 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.0 | 0.2 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.0 | 0.4 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.1 | GO:0098960 | postsynaptic neurotransmitter receptor activity(GO:0098960) |
0.0 | 0.3 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 0.4 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.0 | 6.8 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 0.2 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
0.0 | 2.2 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.6 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.4 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.5 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.0 | 0.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.4 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 0.1 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.0 | 0.3 | GO:0031005 | filamin binding(GO:0031005) |
0.0 | 0.1 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.0 | 0.5 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.4 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.0 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.0 | 0.2 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.0 | 0.6 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.3 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.0 | 0.2 | GO:0043176 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
0.0 | 0.5 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.3 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.4 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.0 | 0.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.0 | 0.2 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 0.3 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.0 | 0.3 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.1 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.2 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.0 | GO:0016768 | spermine synthase activity(GO:0016768) |
0.0 | 0.1 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 1.9 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.0 | 0.1 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 0.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.0 | 0.3 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 7.3 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.0 | 0.6 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.0 | 0.1 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.0 | 0.0 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.1 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.0 | 0.5 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.1 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.0 | 0.3 | GO:0016874 | ligase activity(GO:0016874) |
0.0 | 0.2 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.0 | 0.2 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 3.6 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.2 | 15.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 13.4 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.2 | 5.9 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.2 | 2.6 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.2 | 9.7 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.2 | 6.4 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 10.9 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 4.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 2.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 1.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 3.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 4.7 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 1.4 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 1.7 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 3.1 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 2.9 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 2.2 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 8.0 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 2.6 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 4.5 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 2.2 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 2.9 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 1.6 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 1.6 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 2.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 1.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 1.0 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 1.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 1.3 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 1.9 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.8 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 3.4 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 1.1 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 1.8 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 2.4 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 1.1 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.0 | 0.3 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.5 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 1.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 2.0 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 1.8 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.7 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 1.0 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 4.7 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.4 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.7 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 7.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 1.4 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.1 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 1.1 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.8 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 2.0 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.6 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.3 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.8 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 1.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.4 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.8 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.8 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.6 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 1.1 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 2.7 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.1 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 0.8 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.4 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.2 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.9 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.3 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 1.3 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.1 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.2 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.3 | 8.0 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.2 | 11.5 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 5.1 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.2 | 14.5 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.2 | 5.6 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 18.0 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 1.8 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 2.9 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 7.9 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 5.2 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 3.2 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 1.1 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 4.2 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.1 | 2.7 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 4.2 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 1.7 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 3.7 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 1.6 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 0.5 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 0.4 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 2.9 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 2.4 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.1 | 3.3 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 4.2 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 0.8 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 2.4 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 1.9 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 1.7 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 1.5 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 2.7 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 1.3 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 2.7 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 1.8 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 1.4 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 2.0 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 5.0 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 1.1 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 1.0 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 6.2 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 2.3 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 2.4 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 1.1 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 2.2 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.7 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.0 | 1.6 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.4 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.0 | 0.9 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.0 | 0.2 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 1.1 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.8 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 0.1 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.0 | 0.9 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 2.1 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.4 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 1.4 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.0 | 0.6 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 0.7 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.0 | 2.1 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.8 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.5 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.2 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 1.1 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 0.7 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.7 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.0 | 0.5 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.5 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 1.3 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.6 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 1.1 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.0 | 0.2 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.3 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 1.7 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.5 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 0.4 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 1.0 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.3 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.0 | 0.5 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.4 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.6 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.3 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 0.2 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 1.2 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 1.0 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.3 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 0.5 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 1.3 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 1.0 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 0.6 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 2.2 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.9 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.8 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.3 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.2 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.0 | 0.3 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.3 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.0 | 0.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 0.4 | REACTOME METABOLISM OF MRNA | Genes involved in Metabolism of mRNA |
0.0 | 1.2 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 0.4 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.0 | 1.1 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.6 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.6 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.4 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.0 | 0.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.4 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.1 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |